Pharmaceutical company Novo Nordisk, maker of blockbuster weight loss drug Wegovy, says its CEO is stepping down.

Wall Street is overwhelmingly optimistic where Nvidia is concerned. Among the 69 analysts who follow the company, 87% have a ...

But Rigetti's stock is taking a breather right now and is down 23% since the beginning of the year. That pullback may make ...

In an abrupt and surprising twist, the CEO of Ozempic-maker Novo Nordisk has been ousted from his position as the head of the ...

OneStream is a mission-critical financial automation platform for enterprises, showing strong revenue and customer growth ...

YieldMax has garnered a reputation for offering intriguing, innovative exchange traded funds (ETFs) with an emphasis on high ...

Danish pharmaceutical company Novo Nordisk, maker of blockbuster weight loss drug Wegovy, said Friday its CEO was stepping ...

Novo Nordisk, maker of weight loss drug Wegovy, says CEO Lars Fruergaard Jorgensen is leaving the company by "mutual ...

Pharmaceutical company Novo Nordisk A/S, maker of blockbuster weight loss drug Wegovy, said Friday its CEO was stepping down ...

Ltd will be in focus next week due to the announcement of its fourth quarterly results for the financial year 2024-25.

Arlo is a standout small-cap investment with impressive subscriber growth, early milestones, and upcoming cost-reducing ...

Novo’s shares have plunged since hitting a record-high in June last year as competition, particularly from Eli Lilly, makes inroads into its market share and as its pipeline of new drugs has ...